Roche Introduces Vabysmo® (faricimab): First Bispecific Monoclonal Antibody for Treating Leading Causes of Vision Loss
Roche Introduces Vabysmo® (faricimab): First Bispecific Monoclonal Antibody for Treating Leading Causes of Vision Loss
Posts
Roche Unveils Ocrevus® (Ocrelizumab) in India, Revolutionizing Multiple Sclerosis (MS) Treatment Landscape with a Breakthrough Therapy
Roche Unveils Ocrevus® (Ocrelizumab) in India, Revolutionizing Multiple Sclerosis (MS) Treatment Landscape with a Breakthrough Therapy
- Get link
- X
- Other Apps